The Prognostic Value of Circulating Tumor Cells in Primary Breast Cancer Prior to any Systematic Therapy: A Systematic Review.
CONCLUSION: Results of this meta-analysis allude CTCs as potent prognostic marker in primary breast cancers prior to any systemic therapy especially when it is studied via CellSearch ® administration, considering that the more the CTCs, the greater the death and relapse rates.
PMID: 30843493 [PubMed - as supplied by publisher]
Source: Current Stem Cell Research and Therapy - Category: Stem Cells Authors: Mansouri S, Hesari PM, Naghavi-Al-Hosseini F, Majidzadeh-A K, Farahmand L Tags: Curr Stem Cell Res Ther Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Databases & Libraries | Stem Cell Therapy | Stem Cells | Study